Transmural remission improves clinical outcomes up to 5 years in Crohn's disease.

Samuel Raimundo FernandesJuliana SerrazinaInês Ayala BottoTiago LealAndreia GuimarãesJoana Lemos GarciaIsadora RosaRita PrataDiana CarvalhoJoão NevesPedro CampeloSofia VenturaAndrea SilvaMariana CoelhoCristiana SequeiraAna Paula OliveiraFrancisco PortelaPaula MinistroHelena Tavares SousaJaime RamosIsabel ClaroRaquel GonçalvesLuís Araújo CorreiaRui Tato MarinhoHelena Cortez-Pinto Fernando Magro

Published in: United European gastroenterology journal (2022)

TR improved clinical outcomes over 5 years of follow-up in CD patients. Distinct but significant benefits were seen with IER and IRR. This suggests that both endoscopic and radiologic remission should be part of the treatment targets of CD.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
disease activity
prognostic factors
rheumatoid arthritis
systemic lupus erythematosus
patient reported outcomes
combination therapy